Canadian operator of long-term care and retirement homes, also providing home healthcare services.
Canadian operator of long-term care and retirement homes, also providing home healthcare services.
Is paid mostly by provincial governments, which fund care for each resident, with residents covering accommodation within regulated limits, so income depends on provincial funding rules and bed occupancy. ParaMed, its home-care unit, is paid under government-funded contracts for nursing and support hours.
In one line: A long-term care/nursing home operator like a smaller Genesis Healthcare.
Moat: narrow (regulatory licence, installed base). Licensed long-term care beds and provincial funding relationships are regulated and slow to expand, limiting new supply.
Headquarters: Markham, Canada · Founded: 1968 · Employees: 28,000
Size Extendicare (EXE.TO) is a Canada Health Care company (Hospital/Nursing Management) with a market value of $1.91B, the 184th largest of 405 Canada companies the cockpit tracks. Shares closed at C$28.81 on 18 Nov 2026.
Performance Over six months the shares fell 16.0%, against +1.6% for the median peer and +1.1% for the Canada market (cap-weighted) — 4th lowest of 21 in its peer set.
Growth Revenue grew 36.2% over the last twelve months (peer median +6.2%); the operating margin is 8.7% (peer median 10.8%).
Valuation It trades at 19.3× forward earnings against a peer median of 35.5× (3rd cheapest of 19).
Price implies For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +2 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 6.3 points above its cost of capital (8.5% WACC).
Next results Next results expected around 4 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | C$2.17B | C$1.66B | C$1.47B | C$1.30B | C$1.22B |
| Revenue growth | — | +13% | +12% | +7% | — |
| Gross profit | C$256M | C$200M | C$168M | C$118M | C$76.8M |
| EBITDA | C$242M | C$176M | C$145M | C$95.2M | C$57.5M |
| Net income | C$131M | C$96.7M | C$75.2M | C$34.0M | -C$4.68M |
| Free cash flow | C$48.8M | C$63.4M | C$101M | -C$105M | -C$3.30M |
| Capital expenditure | C$92.0M | C$102M | C$42.0M | C$129M | C$102M |
| Total debt | C$590M | C$330M | C$292M | C$335M | C$384M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Extendicare EXE.TO | $1.91B | -16% | +36% | 9% | 19.3× | 10.8% |
| Sienna Senior Living SIA.TO | $1.58B | -8% | +15% | 10% | 40.9× | 18.9% |
| Chartwell Retirement Residences CSH-UN.TO | $4.94B | +2% | +21% | 14% | 50.7× | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | EXE.TO | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +4.8% | +1.7% | 8th highest of 21 |
| 6-month return | -16.0% | +1.6% | 4th lowest of 21 |
| Distance from 52-week high | -26.4% | -16.9% | 6th lowest of 21 |
| Revenue growth (TTM) | +36.2% | +6.2% | 2nd highest of 21 |
| Operating margin | 8.7% | 10.8% | 9th lowest of 21 |
| Forward P/E | 19.3× | 35.5× | 3rd cheapest of 19 |
| Growth the price implies (Req g, 7 yrs) | 10.8% | 12.7% | 7th least demanding of 16 |
| Growth delivered (Del g) | +8.5% | +10.2% | 5th lowest of 16 |
| Hurdle (Req g minus delivered) | +2.3 pp | +3.4 pp | 8th least demanding of 16 |
| ROIC minus cost of capital | +6.3 pp | -2.7 pp | 3rd highest of 21 |
| EV / EBITDA | 13.4× | 14.9× | 7th cheapest of 14 |
| Net debt / EBITDA | 2.1× | 3.0× | 7th least indebted of 16 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Extendicare EXE.TO | Canada | $1.91B | -16% | +36% | 9% | 19.3× | 10.8% | +8.5% |
| Ardent Health ARDT | United States | $2.03B | +52% | +2% | 5% | 11.9× | -1.7% | +8.7% |
| Huaxia Eye Hospital 301267.SZ | China | $1.78B | -18% | +2% | 15% | 23.5× | 2.1% | +10.4% |
| Brookdale Senior Living BKD | United States | $2.06B | -36% | -8% | 6% | 482.6× | 19.3% | -1.4% |
| Sienna Senior Living SIA.TO | Canada | $1.58B | -8% | +15% | 10% | 40.9× | 18.9% | +8.6% |
| Topchoice Medical 600763.SS | China | $2.33B | -12% | +7% | 26% | 24.8× | 12.4% | +6.9% |
| Xi'an International Medical Investment 000516.SZ | China | $1.46B | -2% | -1% | -2% | n/a | 12.7% | +20.6% |
| Aevis Victoria AEVS.SW | Switzerland | $1.43B | +8% | +15% | -6% | 106.8× | 26.5% | +10.2% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.37B | -7% | +23% | 22% | 40.4× | 30.7% | +21.2% |
| Sanbo Hospital Management 301293.SZ | China | $1.35B | -29% | +17% | 6% | 135.5× | n/a | n/a |
| Spire Healthcare SPI.L | United Kingdom | $1.31B | +11% | +2% | 8% | 25.1× | 10.0% | +11.4% |
| Raffles Medical BSL.SI | Singapore | $1.23B | -13% | -3% | 11% | 27.1× | -2.7% | +6.1% |
| CVS CVSG.L | United Kingdom | $1.22B | +17% | +6% | 11% | 14.6× | 14.2% | +6.9% |
| National HealthCare NHC | United States | $3.16B | +1% | +6% | 0% | n/a | 6.4% | +9.7% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.13B | +31% | +50% | 16% | 49.4× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 30.6× | 22.1% | +10.2% |
| Krishna Institute of Medical Sciences KIMS.NS | India | $3.41B | +2% | +35% | 11% | 81.9× | n/a | n/a |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 22.5× | n/a | n/a |
| Surgery Partners SGRY | United States | $3.53B | +100% | +2% | 13% | 77.2× | 15.6% | +12.2% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 48.8× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 20.1× | 2.3% | +19.7% |